Should Persistent Hepatitis E Virus Replication in Transplant Patients Be Tolerated?

被引：2
|
作者：
Kamar, Nassim [1 ,2 ]
Del Bello, Arnaud [1 ]
Izopet, Jacques [2 ,3 ]
机构：
[1] CHU Rangueil, Dept Nephrol & Organ Transplantat, TSA 50032, F-31059 Toulouse 9, France
[2] Toulouse Univ Paul Sabatier, Ctr Pathophysiol Toulouse Purpan, Toulouse, France
[3] Natl Reference Ctr Hepatitis E Virus, Dept Virol, Toulouse, France
来源：
TRANSPLANTATION | 2018年 / 102卷 / 02期
关键词：
RIBAVIRIN; INFECTION; FIBROSIS;
D O I：
10.1097/TP.0000000000001994
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：e84 / e85
页数：2
相关论文
共 50 条
  • [1] Should Persistent Hepatitis E Virus Replication in Transplant Patients Be Tolerated? Reply
    Mazzola, Alessandra
    Margherita Tran Minh
    Charlotte, Frederic
    Hdiji, Aisha
    Bernard, Denis
    Wendum, Dominic
    Calmus, Yvon
    Conti, Filomena
    TRANSPLANTATION, 2018, 102 (02) : e85 - e86
  • [2] Toward Systematic Screening for Persistent Hepatitis E Virus Infections in Transplant Patients
    Ankcorn, Michael J.
    Ijaz, Samreen
    Poh, John
    Elsharkawy, Ahmed M.
    Smit, Erasmus
    Cramb, Robert
    Ravi, Swathi
    Martin, Kate
    Tedder, Richard
    Neuberger, James
    TRANSPLANTATION, 2018, 102 (07) : 1139 - 1147
  • [3] Hepatitis E Virus: What Transplant Physicians Should Know
    Kamar, N.
    Legrand-Abravanel, F.
    Izopet, J.
    Rostaing, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (09) : 2281 - 2287
  • [4] When Should Ribavirin Be Started to Treat Hepatitis E Virus Infection in Transplant Patients?
    Kamar, N.
    Marion, O.
    Izopet, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (02) : 727 - 727
  • [5] Rat Hepatitis E Virus as Cause of Persistent Hepatitis after Liver Transplant
    Sridhar, Siddharth
    Yip, Cyril C. Y.
    Wu, Shusheng
    Cai, Jianpiao
    Zhang, Anna Jin-Xia
    Leung, Kit-Hang
    Chung, Tom W. H.
    Chan, Jasper F. W.
    Chan, Wan-Mui
    Teng, Jade L. L.
    Au-Yeung, Rex K. H.
    Cheng, Vincent C. C.
    Chen, Honglin
    Lau, Susanna K. P.
    Woo, Patrick C. Y.
    Xia, Ning-Shao
    Lo, Chung-Mau
    Yuen, Kwok-Yung
    EMERGING INFECTIOUS DISEASES, 2018, 24 (12) : 2241 - 2250
  • [6] Hepatitis E Virus Replication
    LeDesma, Robert
    Nimgaonkar, Ila
    Ploss, Alexander
    VIRUSES-BASEL, 2019, 11 (08):
  • [7] Loss of antibodies to hepatitis E virus in organ transplant patients with hepatitis E
    Oshiro, Yukio
    Harada, Hiroshi
    Hasegawa, Kiyoshi
    Akutsu, Naotake
    Yoshizumi, Tomoharu
    Kawagishi, Naoki
    Nanmoku, Koji
    Ichimaru, Naotsugu
    Okamura, Kenichi
    Ohira, Masahiro
    Itabashi, Yoshihiro
    Fujiyama, Nobuhiro
    Ide, Kentaro
    Okajima, Hideaki
    Ogawa, Kohei
    Takagi, Kosei
    Eguchi, Hidetoshi
    Shinoda, Masahiro
    Nishida, Kiyotaka
    Shimazaki, Jiro
    Shimoda, Mitsugi
    Takahashi, Masaharu
    Okamoto, Hiroaki
    Suzuki, Shuji
    HEPATOLOGY RESEARCH, 2021, 51 (05) : 538 - 547
  • [8] Chronic hepatitis associated with Hepatitis E virus in organ transplant patients
    Pillet, S.
    VIROLOGIE, 2008, 12 (02) : 142 - 144
  • [9] Treatment of hepatitis B virus replication by ganciclovir in kidney transplant patients
    Garnier, JL
    Chossegros, P
    Daoud, S
    Chevallier, P
    Dubernard, JM
    Trepo, C
    Touraine, JL
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 817 - 817
  • [10] Ledipasvir/sofosbuvir is effective and well tolerated in postkidney transplant patients with chronic hepatitis C virus
    Morales, Amilcar L.
    Liriano-Ward, Luz
    Tierney, Amber
    Sang, Michelle
    Lalos, Alexander
    Hassan, Mohamed
    Nair, Vinay
    Schiano, Thomas
    Satoskar, Rohit
    Smith, Coleman
    CLINICAL TRANSPLANTATION, 2017, 31 (05)
12345